Arena Investors’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Arena Investors’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,000	Closed	-$499K	–	134
2022 Q3	$499K	Hold	50,000	–	–	0.23%	76
2022 Q2	$494K	Hold	50,000	–	–	0.22%	74
2022 Q1	$492K	Buy	+50,000	New	+$490K	0.32%	59

Arena Investors's FLAC Position: Q4 2022 in Review

Arena Investors sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 50,000 shares — an estimated $499K sold.

Arena Investors first reported a position in FLAC in Q1 2022 and held it in 3 quarters. The position peaked at $499K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Arena Investors reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Arena Investors sold 50,000 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $499K.
Arena Investors first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2022 and held it in 3 quarters.
Arena Investors's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $499K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Arena Investors's 13F filing for Q4 2022, filed 14 Feb 2023.